Artykuły w czasopismach na temat „Vaccines Effectiveness”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Vaccines Effectiveness”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Trombetta, Claudia Maria, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani i Serena Marchi. "Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines". Vaccines 10, nr 5 (1.05.2022): 714. http://dx.doi.org/10.3390/vaccines10050714.
Pełny tekst źródłaHelena De Oliveira, Lucia, Barbara Jauregui, Ana Flavia Carvalho i Norberto Giglio. "Impact and effectiveness of meningococcal vaccines: a review". Revista Panamericana de Salud Pública 41 (20.12.2017): 1. http://dx.doi.org/10.26633/rpsp.2017.158.
Pełny tekst źródłaPálinkás, Anita, i János Sándor. "Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study". Vaccines 10, nr 7 (24.06.2022): 1009. http://dx.doi.org/10.3390/vaccines10071009.
Pełny tekst źródłaKamolratanakul, Supitcha, i Punnee Pitisuttithum. "Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer". Vaccines 9, nr 12 (30.11.2021): 1413. http://dx.doi.org/10.3390/vaccines9121413.
Pełny tekst źródłaIzurieta, Hector S., Yoganand Chillarige, Jeffrey Kelman, Yuqin Wei, Yun Lu, Wenjie Xu, Michael Lu i in. "Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019". Journal of Infectious Diseases 222, nr 2 (26.02.2020): 278–87. http://dx.doi.org/10.1093/infdis/jiaa080.
Pełny tekst źródłaDiogo José Horst i Charles Adriano Duvoisin. "The doubtful effectiveness of the COVID-19 vaccine". GSC Biological and Pharmaceutical Sciences 15, nr 2 (30.05.2021): 151–57. http://dx.doi.org/10.30574/gscbps.2021.15.2.0132.
Pełny tekst źródłaKnight-Jones, T. J. D., K. Edmond, S. Gubbins i D. J. Paton. "Veterinary and human vaccine evaluation methods". Proceedings of the Royal Society B: Biological Sciences 281, nr 1784 (7.06.2014): 20132839. http://dx.doi.org/10.1098/rspb.2013.2839.
Pełny tekst źródłaStöckli, Sabrina, Anna Katharina Spälti, Joseph Phillips, Florian Stoeckel, Matthew Barnfield, Jack Thompson, Benjamin Lyons, Vittorio Mérola, Paula Szewach i Jason Reifler. "Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment". PLOS ONE 17, nr 5 (4.05.2022): e0266003. http://dx.doi.org/10.1371/journal.pone.0266003.
Pełny tekst źródłaErofeeva, M. K., M. A. Stukova, E. V. Shakhlanskaya, Zh V. Buzitskaya, V. L. Maksakova, T. I. Krainova, M. M. Pisareva, A. B. Popov, M. G. Pozdnjakova i D. A. Lioznov. "Evaluation of the Preventive Effectiveness of Influenza Vaccines in the Epidemic Season 2019–2020 in St. Petersburg". Epidemiology and Vaccinal Prevention 20, nr 5 (5.11.2021): 52–60. http://dx.doi.org/10.31631/2073-3046-2021-20-5-52-60-52-60.
Pełny tekst źródłaRajaram, Sankarasubramanian, Constantina Boikos, Daniele K. Gelone i Ashesh Gandhi. "Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing". Therapeutic Advances in Vaccines and Immunotherapy 8 (styczeń 2020): 251513552090812. http://dx.doi.org/10.1177/2515135520908121.
Pełny tekst źródłaNsanzimana, Sabin, Alind Gupta, Jean Paul Uwizihiwe, Jonas Haggstrom, Louis Dron, Paul Arora i Jay J. H. Park. "The Need for a Practical Approach to Evaluate the Effectiveness of COVID-19 Vaccines for Low- and Middle-Income Countries". American Journal of Tropical Medicine and Hygiene 105, nr 3 (15.09.2021): 561–63. http://dx.doi.org/10.4269/ajtmh.21-0482.
Pełny tekst źródłaAmado Xavier de Oliveira, Ana Cecilia, Isabella Fernandes Delgado i Francisco José Roma Paumgartten. "On the safety and effectiveness of COVID-19 vaccines, certainties and uncertainties". Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia 9, nr 4 (30.11.2021): 16–24. http://dx.doi.org/10.22239/2317-269x.01881.
Pełny tekst źródłaVarghese, Tintu, Gagandeep Kang i Andrew Duncan Steele. "Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality". Vaccines 10, nr 3 (23.02.2022): 346. http://dx.doi.org/10.3390/vaccines10030346.
Pełny tekst źródłaLiu, Chuyao, Aiyun Lu i Xiaoyu Wu. "COVID-19 Vaccine Comparison: How to Choose the Best Suiting Vaccine for Different Needs". E3S Web of Conferences 292 (2021): 03080. http://dx.doi.org/10.1051/e3sconf/202129203080.
Pełny tekst źródłaFolorunso, Olufemi Samuel, i Olihile M. Sebolai. "Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines". Vaccines 8, nr 3 (27.06.2020): 341. http://dx.doi.org/10.3390/vaccines8030341.
Pełny tekst źródłaKhandker, Shahad Saif, Brian Godman, Md Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md Ahsanul Haq i in. "A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues". Vaccines 9, nr 12 (24.11.2021): 1387. http://dx.doi.org/10.3390/vaccines9121387.
Pełny tekst źródłaSabin, A. "Effectiveness of AIDS vaccines". Science 251, nr 4998 (8.03.1991): 1161. http://dx.doi.org/10.1126/science.2015033.
Pełny tekst źródłaNaranbhai, Vivek, Wilfredo F. Garcia-Beltran, Christina C. Chang, Cristhian Berrios Mairena, Julia C. Thierauf, Grace Kirkpatrick, Maristela L. Onozato i in. "Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines". Journal of Infectious Diseases 225, nr 7 (9.12.2021): 1141–50. http://dx.doi.org/10.1093/infdis/jiab593.
Pełny tekst źródłaChristensen, Hannah, Hareth Al-Janabi, Pierre Levy, Maarten J. Postma, David E. Bloom, Paolo Landa, Oliver Damm i in. "Economic evaluation of meningococcal vaccines: considerations for the future". European Journal of Health Economics 21, nr 2 (21.11.2019): 297–309. http://dx.doi.org/10.1007/s10198-019-01129-z.
Pełny tekst źródłaVijayalakshmi, S., K. Manivannane i N. Malarvizhi. "Efficacy of Vaccine and Administration of Vaccine for all the Individuals against SARS-CoV-19 and the Variants". Shanlax International Journal of Arts, Science and Humanities 9, nr 2 (1.10.2021): 148–56. http://dx.doi.org/10.34293/sijash.v9i2.4384.
Pełny tekst źródłaCho, Hyun-Il, Young-Ran Lee i Esteban Celis. "Interferon γ limits the effectiveness of melanoma peptide vaccines". Blood 117, nr 1 (6.01.2011): 135–44. http://dx.doi.org/10.1182/blood-2010-08-298117.
Pełny tekst źródłaThiele, Sonja, Aljona Borschewski, Judit Küchler, Marc Bieberbach, Sebastian Voigt i Bernhard Ehlers. "Molecular Analysis of Varicella Vaccines and Varicella-Zoster Virus from Vaccine-Related Skin Lesions". Clinical and Vaccine Immunology 18, nr 7 (11.05.2011): 1058–66. http://dx.doi.org/10.1128/cvi.05021-11.
Pełny tekst źródłaVaezi, Atefeh, i Alipasha Meysamie. "COVID-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran". Vaccines 10, nr 1 (29.12.2021): 37. http://dx.doi.org/10.3390/vaccines10010037.
Pełny tekst źródłaGao, Hao, Qingting Zhao, Chuanlin Ning, Difan Guo, Jing Wu i Lina Li. "Does the COVID-19 Vaccine Still Work That “Most of the Confirmed Cases Had Been Vaccinated”? A Content Analysis of Vaccine Effectiveness Discussion on Sina Weibo during the Outbreak of COVID-19 in Nanjing". International Journal of Environmental Research and Public Health 19, nr 1 (26.12.2021): 241. http://dx.doi.org/10.3390/ijerph19010241.
Pełny tekst źródłaTomaszewski, Tre, Alex Morales, Ismini Lourentzou, Rachel Caskey, Bing Liu, Alan Schwartz i Jessie Chin. "Identifying False Human Papillomavirus (HPV) Vaccine Information and Corresponding Risk Perceptions From Twitter: Advanced Predictive Models". Journal of Medical Internet Research 23, nr 9 (9.09.2021): e30451. http://dx.doi.org/10.2196/30451.
Pełny tekst źródłaMahumud, Rashidul Alam, Mohammad Afshar Ali, Satyajit Kundu, Md Ashfikur Rahman, Joseph Kihika Kamara i Andre M. N. Renzaho. "Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis". Vaccines 10, nr 2 (11.02.2022): 277. http://dx.doi.org/10.3390/vaccines10020277.
Pełny tekst źródłaFanelli, Angela, Luca Mantegazza, Saskia Hendrickx i Ilaria Capua. "Thermostable Vaccines in Veterinary Medicine: State of the Art and Opportunities to Be Seized". Vaccines 10, nr 2 (5.02.2022): 245. http://dx.doi.org/10.3390/vaccines10020245.
Pełny tekst źródłaRizzo, Caterina, Francesco Gesualdo, Daniela Loconsole, Elisabetta Pandolfi, Antonino Bella, Andrea Orsi, Giulia Guarona i in. "Moderate Vaccine Effectiveness against Severe Acute Respiratory Infection Caused by A(H1N1)pdm09 Influenza Virus and No Effectiveness against A(H3N2) Influenza Virus in the 2018/2019 Season in Italy". Vaccines 8, nr 3 (30.07.2020): 427. http://dx.doi.org/10.3390/vaccines8030427.
Pełny tekst źródłaBaum, Ulrike, Sangita Kulathinal, Kari Auranen i Hanna Nohynek. "Effectiveness of 2 Influenza Vaccines in Nationwide Cohorts of Finnish 2-Year-Old Children in the Seasons 2015–2016 Through 2017–2018". Clinical Infectious Diseases 71, nr 8 (19.01.2020): e255-e261. http://dx.doi.org/10.1093/cid/ciaa050.
Pełny tekst źródłaLau, Chin Shern, i Tar Choon Aw. "Considerations in Understanding Vaccine Effectiveness". Vaccines 11, nr 1 (22.12.2022): 20. http://dx.doi.org/10.3390/vaccines11010020.
Pełny tekst źródłaMarra, Yasmin, i Fawziah Lalji. "Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines". Viruses 14, nr 12 (29.11.2022): 2667. http://dx.doi.org/10.3390/v14122667.
Pełny tekst źródłaLu, Jia, Xiaosa Wen, Qi Guo, Mengdi Ji, Felicia Zhang, Abram L. Wagner i Yihan Lu. "Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China". Vaccines 9, nr 5 (7.05.2021): 472. http://dx.doi.org/10.3390/vaccines9050472.
Pełny tekst źródłavan den Berg, Jesse M., Sharon Remmelzwaal, Marieke T. Blom, Beryl A. C. E. van Hoek, Karin M. A. Swart, Jetty A. Overbeek, George L. Burchell, Ron M. C. Herings i Petra J. M. Elders. "Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review". Vaccines 11, nr 1 (22.12.2022): 24. http://dx.doi.org/10.3390/vaccines11010024.
Pełny tekst źródłaNdawula, Charles. "From Bench to Field: A Guide to Formulating and Evaluating Anti-Tick Vaccines Delving beyond Efficacy to Effectiveness". Vaccines 9, nr 10 (15.10.2021): 1185. http://dx.doi.org/10.3390/vaccines9101185.
Pełny tekst źródłaGeorge, Gavin, Michael Strauss, Emma Lansdell, Nisha Nadesan-Reddy, Nomfundo Moroe, Tarylee Reddy, Ingrid Eshun-Wilsonova i Mosa Moshabela. "South African University Staff and Students’ Perspectives, Preferences, and Drivers of Hesitancy Regarding COVID-19 Vaccines: A Multi-Methods Study". Vaccines 10, nr 8 (4.08.2022): 1250. http://dx.doi.org/10.3390/vaccines10081250.
Pełny tekst źródłaRockman, Steven, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran i John Youhanna. "Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness". Vaccines 11, nr 1 (26.12.2022): 52. http://dx.doi.org/10.3390/vaccines11010052.
Pełny tekst źródłaNugroho, Setiyo Adi, i Indra Nur Hidayat. "Efektivitas Dan Keamanan Vaksin Covid-19 : Studi Refrensi". Jurnal Keperawatan Profesional 9, nr 2 (18.08.2021): 61–107. http://dx.doi.org/10.33650/jkp.v9i2.2767.
Pełny tekst źródłaMarkelova, E. V., S. V. Knysh i M. P. Kostinov. "Vaccination against COVID-19 Patients with Allergic Diseases. The Position of the Allergologist-Immunologist. Literature review". Epidemiology and Vaccinal Prevention 21, nr 2 (11.05.2022): 91–97. http://dx.doi.org/10.31631/2073-3046-2022-21-2-91-97.
Pełny tekst źródłaPizza, Mariagrazia, Rafik Bekkat-Berkani i Rino Rappuoli. "Vaccines against Meningococcal Diseases". Microorganisms 8, nr 10 (3.10.2020): 1521. http://dx.doi.org/10.3390/microorganisms8101521.
Pełny tekst źródłaAlamer, Edrous, Faisal Hakami, Sulaiman Hamdi, Afnan Alamer, Mohammed Awaf, Hussam Darraj, Yumna Abutalib i in. "Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia". Vaccines 9, nr 11 (1.11.2021): 1259. http://dx.doi.org/10.3390/vaccines9111259.
Pełny tekst źródłaMentzer, Alexander J., Daniel O'Connor, Andrew J. Pollard i Adrian V. S. Hill. "Searching for the human genetic factors standing in the way of universally effective vaccines". Philosophical Transactions of the Royal Society B: Biological Sciences 370, nr 1671 (19.06.2015): 20140341. http://dx.doi.org/10.1098/rstb.2014.0341.
Pełny tekst źródłaCostantino, Claudio, Alessandra Casuccio i Vincenzo Restivo. "Vaccination and Vaccine Effectiveness: A Commentary of Special Issue Editors". Vaccines 8, nr 3 (18.09.2020): 545. http://dx.doi.org/10.3390/vaccines8030545.
Pełny tekst źródła&NA;. "Pneumococcal vaccines: effectiveness in adults". Inpharma Weekly &NA;, nr 1297 (lipiec 2001): 4. http://dx.doi.org/10.2165/00128413-200112970-00008.
Pełny tekst źródłaWalker, Damian, i Richard Rheingans. "Cost–effectiveness of rotavirus vaccines". Expert Review of Pharmacoeconomics & Outcomes Research 5, nr 5 (październik 2005): 593–601. http://dx.doi.org/10.1586/14737167.5.5.593.
Pełny tekst źródłaKaur, Upinder, Sapna Bala, Aditi Joshi, Noti Taruni Srija Reddy, Chetan Japur, Mayank Chauhan, Nikitha Pedapanga i in. "Persistent Health Issues, Adverse Events, and Effectiveness of Vaccines during the Second Wave of COVID-19: A Cohort Study from a Tertiary Hospital in North India". Vaccines 10, nr 7 (20.07.2022): 1153. http://dx.doi.org/10.3390/vaccines10071153.
Pełny tekst źródłaDrácz, Bálint, Veronika Müller, István Takács, Krisztina Hagymási, Elek Dinya, Pál Miheller, Attila Szijártó i Klára Werling. "Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study". Vaccines 11, nr 1 (26.12.2022): 50. http://dx.doi.org/10.3390/vaccines11010050.
Pełny tekst źródłaLisitskaya, L. A., A. V. Kolesnikov, A. V. Kozyr, I. G. Shemyakin, A. K. Ryabko, O. N. Krasavtseva i LA Dyatlov. "PROTEINS AND OTHER CARRIERS FOR CREATION OF CONJUGATED VACCINES: PROPERTIES AND APPLICATION". Journal of microbiology, epidemiology and immunobiology, nr 4 (28.08.2016): 115–24. http://dx.doi.org/10.36233/0372-9311-2016-4-115-124.
Pełny tekst źródłaWen, Frank, Sidney Bell, Trevor Bedford i Sarah Cobey. "Estimating Vaccine-Driven Selection in Seasonal Influenza". Viruses 10, nr 9 (18.09.2018): 509. http://dx.doi.org/10.3390/v10090509.
Pełny tekst źródłaGreener, Mark. "Influenza vaccines: an introduction". Practice Nursing 34, Sup1 (2.01.2023): 10–16. http://dx.doi.org/10.12968/pnur.2023.34.sup1.s10.
Pełny tekst źródłaMa, Yirui, Jie Deng, Qiao Liu, Min Du, Min Liu i Jue Liu. "Effectiveness and Safety of COVID-19 Vaccine among Pregnant Women in Real-World Studies: A Systematic Review and Meta-Analysis". Vaccines 10, nr 2 (6.02.2022): 246. http://dx.doi.org/10.3390/vaccines10020246.
Pełny tekst źródła